erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
it shows that the longest waits for cancer treatment have soared since 2010.
.
.
.
.
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�
.
.
'i mean all she pretty much did was spread the word and reach out to her baby daddies, so she felt like, "that's how i helped, " continued the insider, referring to ex